Drugs / Tacrolimus Extended Release Capsule
last change Dec 2018 re-read 9 days ago

Tacrolimus Extended Release Capsule

Developed for
immunodeficiency disease
Investigated by
Astellas Pharma Inc · Medical University of South Carolina

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02953873 May 2017 → Sep 2018 immunodeficiency disease Medical University of South Carolina Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tacrolimus Extended Release Capsule ClinicalTrials.gov intervention name — accepted as the source's own label NCT02953873 ↗